Skip to main content
University of Michigan Innovation Partnerships
University of Michigan Innovation Partnerships


Neurable approaches launch with noninvasive brain-computer interface

Fresh off a second-place finish at the Rice Business Plan Competition and a $280,000 prize from Owl Investment Group, University of Michigan startup Neurable is fast approaching launch. The company, formed recently to commercialize a noninvasive brain-computer interface that was developed at U-M’s Direct Brain Interface Lab, is currently in...

Phase Four makes satellites maneuverable with the Cubesat Ambipolar Thruster (CAT)

Phase Four is shooting for the stars with its revolutionary technology that will significantly improve the value of satellites in space. Using plasma propulsion technology licensed from the University of Michigan, Phase Four is pioneering the ability for CubeSats (small satellites) to move in space versus travel in a set...

Crossbar: Positioned to Change the Computer Memory Industry

Imagine a smart phone able to store 250 hours of HD video. A thumb drive that contains 250,000 songs. An iPod battery that can hold a charge for a week. These capabilities—and more—will soon be available, thanks to a transformational technology known as RRAM (Resistive Random Access Memory) developed at...

AlertWatch: Heads Up Display for Anesthesiologists

Professor and Chair of Anesthesiology Kevin Tremper has been creating innovative medical monitoring technologies for more than three decades. Like all of his inventions, Tremper’s latest technology was developed in response to a specific set of needs. As he explains, “In operating rooms and ICUs across the country, patient monitoring...

Millendo Raises $62M to Bring Women’s Health Therapeutics to Market

In January 2016, University of Michigan startup Millendo Therapeutics announced that it had raised $62 million in Series B investment. In addition, the company, which was previously know as Atterocor, announced that they had endeared into an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to...

SenSigma: Smart Optical Monitoring Systems

Defect formation is a highly problematic part of the manufacturing process. Every year, faulty products cause billions of dollars in material costs and production delays. U-M Mechanical Engineering and Materials Science Professor Jyoti Mazumder first became interested in online detection of defects for car body fabrication more than 12 years...

Reprogramming Brain Circuits to Alleviate the Symptoms of Tinnitus

An innovative treatment for a common hearing disorder… For the nearly 50 million Americans who suffer from the hearing condition tinnitus, every moment of every day is filled with unwanted noise. Whether it manifests as ringing, hissing, humming or buzzing, that non-stop sound can be disruptive and even debilitating. U-M...

Technology for the Athlete’s Toolbox: Motion Tracking for Improved Performance

Fourteen years ago, Professor Noel Perkins had no idea that his love of fly fishing would result in a transformative technology for sports training. At the time, he had just one goal: improve his fly casting. Frustrated with books and videos, he attached an angular-rate gyroscope to the grip of...

Changing the Future of Mobility: Advanced Transportation Innovation

Research partnerships and innovations from the University of Michigan and our industry partners are creating exciting advances in automobile and other forms of transportation. U-M researchers are key contributors in many areas, including electrification technologies, digital solutions (connected vehicles and mobility), advanced materials (safety and improved fuel economy) and energy...

Menin-MLL Inhibitors: A Potential Treatment for a Rare and Deadly Leukemia

Oncology researchers Jolanta Grembecka and Tomasz Cierpicki began what they refer to as their “adventures in drug discovery” at the University of Virginia, where they focused on treatments for leukemia-related diseases. Their ultimate goal has always been to create new small molecules for protein targets neglected by industry—what are known...

The Neuroma Surgical Tool: Advancing Treatments for Amputees

Each year, approximately 185,000 amputations are performed in this country. One of the biggest challenges facing amputees is constant, severe pain caused by neuromas—balls of raw nerve fiber that grow at the end of severed nerves. Research conducted by U-M Professor of Plastic Surgery Paul Cederna demonstrated that this pain...

GENOMENON: Empowering Personalized Medicine

Genome sequencing has revolutionized the health care field, opening the way to a new era of personalized medicine. It is now possible to sequence the entire human genome—all 3 billion letters of information— in about a day. But analyzing and interpreting the data is a slow, error-prone process that can...
1 4 5 6 7 8